In non-small cell lung cancer (NSCLC) patients with overweight or obesity, metformin may improve lung cancer-specific ...

Metformin may improve lung cancer-specific clinical outcomes in obese and overweight lung cancer patients and enhance immunotherapy efficacy in this growing population as well,” researchers concluded.

As junk food becomes a staple, a top GP sounds the alarm on Britain's looming health crisis, suggesting our diets are more ...

Two new studies identified additional benefits of medications like semaglutide—the active ingredient in Novo Nordisk's ...

A UCLA study has outlined a new framework that researchers say would improve predictive power of genetics to determine how well a patient would respond to commonly prescribed medications as well as ...

Cory Ruth, a registered dietitian and women's health expert, first started noticing irregular periods in her teens. "I remember always feeling like something was off. In high ...

Serious outcomes associated with metabolic dysfunction-associated steatotic liver disease (MASLD) -- including liver cancer, ...

New research shows metformin can help obese people with lung cancer battle that disease by boosting the benefits of ...

A widely accessible drug commonly used to control blood glucose levels in diabetic patients has the potential to strengthen ...

It's thought that metformin helps boost the benefits of immunotherapy cancer drugs WEDNESDAY, Nov. 27, 2024 (HealthDay News) -- Already the go-to drug of choice for millions with type 2 diabetes, ...

WEDNESDAY, Nov. 27, 2024 (HealthDay News) -- Already the go-to drug of choice for millions with type 2 diabetes, metformin ...